Incorporation of CEA Improves Risk Stratification in Stage II Colon Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incorporation of CEA Improves Risk Stratification in Stage II Colon Cancer
Authors
Keywords
CEA, Colon cancer, Staging, Risk stratification
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 21, Issue 5, Pages 770-777
Publisher
Springer Nature
Online
2017-03-13
DOI
10.1007/s11605-017-3391-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDX2: Linking Cell and Patient Fates in Colon Cancer
- (2016) Eric R. Fearon et al. Cell Stem Cell
- Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery
- (2016) Chun-Dong Zhang et al. MEDICINE
- CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
- (2016) Piero Dalerba et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy
- (2016) Elizabeth A. Mittendorf et al. JAMA Oncology
- Preoperative serum markers for individual patient prognosis in stage I–III colon cancer
- (2015) Clemens Giessen-Jung et al. TUMOR BIOLOGY
- Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival
- (2015) Pragatheeshwar Thirunavukarasu et al. JAMA Surgery
- Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer
- (2014) Aalok Kumar et al. CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preoperative carcinoembryonic antigen as an outcome predictor in colon cancer
- (2013) Ramzi Amri et al. JOURNAL OF SURGICAL ONCOLOGY
- Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery
- (2013) Zheng Lou WORLD JOURNAL OF GASTROENTEROLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management
- (2011) Pragatheeshwar Thirunavukarasu et al. JNCI-Journal of the National Cancer Institute
- AJCC Cancer Staging Manual
- (2010) James R. Egner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Using the NCDB for cancer care improvement: An introduction to available quality assessment tools
- (2009) Mehul V. Raval et al. JOURNAL OF SURGICAL ONCOLOGY
- Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy
- (2008) Hak-Mien Quah et al. DISEASES OF THE COLON & RECTUM
- Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer
- (2008) Yutaka Ogata et al. JOURNAL OF SURGICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started